fbpx

What makes your A. B. Nicholas portfolio loan way better…

  • Lowest interest rates in the market. 
  • Tightest security and licensing.
  • Best reputation over ten years of service (BBB A+)
  • We do all the work so you don’t have to, when you are looking for a stock portfolio loan. 
  • We’ve assembled the most accomplished, experienced, licensed FINRA-member institutions and advisors to produce our LeverageLine model of stock loan financing for you.


Our business — in the hundreds of millions over the decade — comes almost exclusively from word of mouth. That should tell you something. 


Learn more here now, then apply for a free quote. You’ll be glad you did. 

Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn
Related Posts

Have Us Speak to Your Salesforce about LeverageLine Credit Lines for Stock Portfolio Owners.

We offer what is arguably the best stock loan program in the U. S. market today, with the lowest rates and highest loan-to-value plus quickest delivery of funds in the nation for a 100% secure, licensed, FINRA-member-managed program. We are A. B. Nicholas, and securities finance is what we do and have done exclusively for over a decade. We have three major household-name licensed institutional brokerages who have agreed to

Why an A. B. Nicholas Stock Loan and Not One from Your Current Brokerage?

When it comes to money, there is a reason why so many financial institutions have named themselves with words like “Trust”, “Fidelity” or “Assurance” for example. That’s because outside perhaps of the medical profession, nowhere else in human life is trust and confidence in the efficacy, honesty, and integrity of a company (or individual) more important.  This applies to stocks, bonds, mutual funds, and so forth too. It is also

A Stock Loan Against Your Cannabis Stock Portfolio? Yep, We Can…

If you have been an investor in one of the many cannabis-related stocks that have sprung up on the boards over the past several years, you’ve probably been stymied when it came to taking out a margin loan against them. Because of the still-existing federal treatment of marijuana as a drug, major banks and brokerages have been unwilling or unable to provide the normal lending facilities against these stocks that

Join Our Weekly Newsletter

We do not sell, communicate or divulge your information to any third-parties.